Forest plot of the risk of gastrointestinal bleeding of NOACs versus... | Download Scientific Diagram
Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors∗ | Journal of the American College of Cardiology
figure50_large.png
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management,
![PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bab146b6bd233e87b294e36dd37d4d71fd77713/7-Table3-1.png "PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar")
PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
IJERPH | Free Full-Text | The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
Reversal Agent vs Supportive Care for NOAC-Related Bleeds: What Do the Data Suggest? (Transcript)
Non-variceal upper gastrointestinal bleeding | Nature Reviews Disease Primers
JCM | Free Full-Text | Characteristics, Location, and Clinical Outcomes of Gastrointestinal Bleeding in Patients Taking New Oral Anticoagulants Compared to Vitamin K Antagonists
Challenging Cases – Upper GI Bleeding on Anticoagulants and Antiplatelets - BroadcastMed
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
Thai Heart - Pathogenesis of NOAC related GI Bleeding | Facebook
IJMS | Free Full-Text | Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases | Journal of Thrombosis and Thrombolysis
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight | Journal of the American College of Cardiology
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis | Thrombosis Journal | Full Text
Frontiers | Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea - Han - 2021 - Journal of Arrhythmia - Wiley Online Library
Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy | PLOS ONE
Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding | Stroke
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer - ScienceDirect
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients - Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian ...
